Ophthalmologists are once again at the forefront of innovation for cosmetic facial procedures. From Botox® to Juvéderm®, eye physicians have been regarded as the experts in the original research and development of injectable, anti-wrinkle treatments. Now, Latisse™, the first and only FDA-approved treatment for inadequate or sparse, thinning eyelashes, has been added to the options for facial enhancement. Its origin is directly from a glaucoma medication that ophthalmologists have been using for the treatment of elevated eye pressure.

Latisse™ solution is a prescription medication used to grow longer, thicker and darker eyelashes. Its effect is gradual, and significant improvement in lash growth can be seen by two months. At the onset of therapy, and at eight and sixteen weeks, I photograph the eyelash area, examine the eyelid and check the eye pressure in each eye with a specialized, high magnification microscope. Patients who have a history of elevated or borderline eye pressure, patients who are taking glaucoma medication or patients with a family history of glaucoma should discuss this before considering treatment with Latisse™. Latisse™ solution is applied with a sterile applicator to the upper eyelid only, and only once a day as directed.

As an ophthalmologist and fellowship-trained oculoplastic surgeon, I recommend that patients consider the credentials of the treating physician, their experience with aesthetic procedures, and their knowledge of eye/eyelid anatomy. Eye plastic surgeons are uniquely qualified as specialists of the eyelid and are able to monitor the eye pressure or any potential ocular/lid adverse effects.

Please visit our Web site www.idocnj.com for more information or to view the new Latisse™ commercial featuring Brooke Shields.

Angela Veloudios, MD, FACS

Angela Veloudios, MD, FACS is a Fellow of the prestigious American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS), one of only approximately 400 surgeons nationally who has received certification for this subspecialty of ophthalmology. Dr. Veloudios is also a Fellow of the American College of Surgeons (F.A.C.S.) She has published numerous journal articles on various topics in her subspecialty. Dr. Veloudios is an attending surgeon at Wills Eye Surgery Center, Cooper University Medical Center, Virtua Memorial, and Lourdes Medical Center of Burlington County.

Copyright Notice: All materials contained on this site are protected by United States copyright law and
may not be reproduced, distributed, transmitted, displayed, published or broadcast without the prior written permission
of Milesetones LLC dba County Woman Magazines or in the case of third party materials, the owner of that content.
You may not alter or remove any trademark, copyright or other notice from copies of the content.

Links to Web sites other than those owned by Milestones LLC dba County Woman Magazines are offered as a
service to readers. Milestones LLC dba County Woman Magazines assumes no responsibility for their content.